News and Comments

VERTEX (VRTX): At the Finish Line

  Monday, August 09, 2010

When an investigational drug proves it can eradicate a virus we call it a breakthrough. The nearest to approval of the expected breakthroughs is Vertex’ (VRTX) drug telaprevir, a specific hepatitis C virus protease inhibitor. The drug was a blessing for the infected victims who had it in clinical trials. It brought a miracle happy ending to what seemed to be an endless nightmare of acute liver inflammation, chronic liver inflammation, liver cirrhosis, liver transplant and possible liver cancer. We expected telaprevir to be greeted by the government and insurance companies, which spend ton of money on the HCV liver problems where treatments that do not work are, nevertheless, paid for.  More...


Recent Postings


Archive


Tags

NOVOCURE (NVCR) ISIS (ISIS) Revlimid (lenolidamide) Jazz Pharmaceuticals (JAZZ) Anadys (ANDS) galapagos (GLPG) OSI (OSIP) Micromet (MITI) KITE (KITE) Dendreon (DNDN) Roche (ROCHE) ARCA (ABIO) Human Longevity (HLI) Benlysta (belimumab) Ziofpharm (ZIOP) PORTOLA (PTLA) JUNO (JUNO) Merck (MRK) Idenix (IDIX) LEXICON (LXRX) GUARDIAN HEALTH NEUROCRINE (NBIX) Herceptin NANTKWEST (NK) C4 Therapeutics Seattle Genetics (SGEN) Pluristem (PSTI) Intermune (ITMN) Elan (ELN) VANDA (VNDA) Abbott Laboratories (ABT) Editas (EDIT) Aimmune Therapeutics (AIMT) SERES THERAPEUTICS (MCRB) Akebia Therapeutics (AKAB) SYNTA (SNTA) Illumina (ILMN) Sangamo (SGMO) Exelixis (EXEL) Regeneron (REGN) Anacor (ANAC) Sanofi-Aventis (SAN) GlycoMimetics (GLYN) Inovio (INO) Spike Therapeutics (ONCE) Velcade (bortezomib) AERIE PHARMACEUTICALS Valeant Pharmaceuticals International (VRX) Cytokinetics (CYTK) Gilead (GILD) Human Genome Sciences (HGSI) Xoma (XOMA) Rapamune Agenus (AGEN) Global Cell Therapeutics (GBT) CompuGen (CGEN) GlaxoSmithKline (GSK) NEKTAR (NKTR)) JOUNCE THERAPEUTICS (JNCE) Genentech Multiple Myeloma Biocryst (BCRX) Adaptimmune (ADAP) ADVENTRIX (ANX) Amgen (AMGN) SUNESIS PHARMACEUTICALS (SNSS) Roche (RHHBY) Biogen Idec (BIIB) INNOVIVA (INVA) ARGOS (ARGS) RenenxBio (RGNX) HALOZYME (HALO) Theravance (THRX) CRISPR Therapeutics (CRSP) Ariad (ARIA) Array Pharmaceuticals (ARRY) Alder Biopharmaceuticals (ALDR) Theravance Bio Pharma (TBPH) Ocular Therapeutix (OCUL) Bristol-Myers Squibb (BMY) AGOS (ARGS) Ridaforolimus Auspex (ASPX) Vitae Pharmaceuticals (VTAE) CEMPRA (CEMP) Intrexon (XON) Epizyme (EPZM) Ionis (IONS) Onyx (ONXX) Mirati Therapeutics (MRTX) IDERA (IDRA) Sanofi (SNA) Tysabri ZALTRAP™ Endometrial Cancer OncoCyte (OCX) Telaprevir PTC Therapeutics (PTCT) AstraZeneca (AZN) ImmunoGen (IMGN) Vertex (VRTX) ACADIA (ACAD) Alnylam (ALNY) Bellicum (BLCM) Galena (GALE) Incyte (INCY) Prosensa (RNA) Dynavax (DVAX) TOKAI (TKAOI) Sequenom (SQNM) BIOMARIN (BMRN) Intercept (ICPT) Trastuzumab-DM1 ABBVIE (ABBV) Prolor Biotech (PBTH) Zerenex Sanofi (SNY) KERYX (KERX) Advaxis (ADXS) REGULUS (RGLS) Sarepta (SRPT) MODERNA Agenus (AGEN